share_log

Does Guilin Layn Natural Ingredients (SZSE:002166) Have A Healthy Balance Sheet?

Does Guilin Layn Natural Ingredients (SZSE:002166) Have A Healthy Balance Sheet?

桂林萊恩天然成分(深圳證券交易所:002166)的資產負債表是否良好?
Simply Wall St ·  05/25 20:59

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's balance sheet when you examine how risky it is, since debt is often involved when a business collapses. We can see that Guilin Layn Natural Ingredients Corp. (SZSE:002166) does use debt in its business. But is this debt a concern to shareholders?

當您了解企業風險程度時,自然會考慮公司的資產負債表,因爲企業破產時常常受到債務的折磨。根據我們所了解的信息,桂林灕江天然生物科技股份有限公司(SZSE:002166)的確使用了債務來經營業務,那麼這些債務對股東來說是不是一個值得關注的問題呢?

When Is Debt Dangerous?

債務何時有危險?

Debt assists a business until the business has trouble paying it off, either with new capital or with free cash flow. In the worst case scenario, a company can go bankrupt if it cannot pay its creditors. While that is not too common, we often do see indebted companies permanently diluting shareholders because lenders force them to raise capital at a distressed price. By replacing dilution, though, debt can be an extremely good tool for businesses that need capital to invest in growth at high rates of return. When we think about a company's use of debt, we first look at cash and debt together.

債務可以幫助企業解決資金短缺的問題,但如果企業在償還債務時遇到問題,當企業不能夠通過新的資本或自由現金流來償還這筆債務時,公司可能會破產。雖然這種情況並不常見,但是我們經常會看到有負債的公司因爲借款人強制他們以低於市價的價格發行股票而永久性稀釋股東權益。不過,在避免稀釋股東權益的前提下,債務可以成爲企業獲得資金投資創業板板塊並獲得高回報率的一種極爲有效的工具。在考慮一個企業使用債務的情況時,我們首先會看到現金和債務兩者之間的關係。

What Is Guilin Layn Natural Ingredients's Net Debt?

桂林灕江天然生物科技股份有限公司的淨債務是多少呢?

You can click the graphic below for the historical numbers, but it shows that Guilin Layn Natural Ingredients had CN¥441.7m of debt in March 2024, down from CN¥601.7m, one year before. However, it does have CN¥248.7m in cash offsetting this, leading to net debt of about CN¥193.0m.

您可以單擊下面的圖形查看歷史數據,其中顯示,截至2024年3月,桂林灕江天然生物科技股份有限公司的債務爲44170萬元人民幣,較一年前的60170萬元人民幣下降。但是,它擁有24870萬元人民幣的現金來抵消這筆債務,從而使淨債務約爲19300萬元人民幣。

debt-equity-history-analysis
SZSE:002166 Debt to Equity History May 26th 2024
SZSE:002166負債股權歷史

How Healthy Is Guilin Layn Natural Ingredients' Balance Sheet?

桂林灕江天然生物科技股份有限公司的資產負債表健康狀況如何?

According to the last reported balance sheet, Guilin Layn Natural Ingredients had liabilities of CN¥1.38b due within 12 months, and liabilities of CN¥201.1m due beyond 12 months. On the other hand, it had cash of CN¥248.7m and CN¥941.4m worth of receivables due within a year. So it has liabilities totalling CN¥392.4m more than its cash and near-term receivables, combined.

根據最新的財務報表,桂林灕江天然生物科技股份有限公司應於12個月內償還138億元人民幣的負債和應超過12個月償還20110萬元人民幣的負債,但它也擁有24870萬元人民幣的現金和94140萬元人民幣的應於一年內到期的應收賬款。因此,合併現金和短期應收賬款後,其負債總額比現金和應收賬款的總額高出39240萬元人民幣。

Given Guilin Layn Natural Ingredients has a market capitalization of CN¥5.91b, it's hard to believe these liabilities pose much threat. Having said that, it's clear that we should continue to monitor its balance sheet, lest it change for the worse.

鑑於桂林灕江天然生物科技股份有限公司的市值達到了591億元人民幣,很難相信這些負債會對公司造成太大的影響。但是,我們需要繼續監測其資產負債表,以防其發生不測。

We measure a company's debt load relative to its earnings power by looking at its net debt divided by its earnings before interest, tax, depreciation, and amortization (EBITDA) and by calculating how easily its earnings before interest and tax (EBIT) cover its interest expense (interest cover). This way, we consider both the absolute quantum of the debt, as well as the interest rates paid on it.

我們通過查看淨債務除以利息、稅、折舊和攤銷前的收益(EBITDA)並計算其利息費用(利息覆蓋)來相對衡量公司的負債水平。這樣,我們考慮債務的絕對規模以及支付的利息費用。

Looking at its net debt to EBITDA of 0.99 and interest cover of 4.2 times, it seems to us that Guilin Layn Natural Ingredients is probably using debt in a pretty reasonable way. But the interest payments are certainly sufficient to have us thinking about how affordable its debt is. Importantly, Guilin Layn Natural Ingredients's EBIT fell a jaw-dropping 42% in the last twelve months. If that earnings trend continues then paying off its debt will be about as easy as herding cats on to a roller coaster. There's no doubt that we learn most about debt from the balance sheet. But it is future earnings, more than anything, that will determine Guilin Layn Natural Ingredients's ability to maintain a healthy balance sheet going forward. So if you want to see what the professionals think, you might find this free report on analyst profit forecasts to be interesting.

我們可以看到,桂林灕江天然生物科技股份有限公司的淨債務與息稅折舊攤銷前利潤比爲0.99,利息覆蓋倍數爲4.2倍,這表明公司的債務使用方式相對合理。但其利息支付令人擔憂,我們需要思考其債務的可持續性。而且,桂林灕江天然生物科技股份有限公司的息稅前利潤較去年同期下降了42%。如果該收入趨勢持續下去,償還債務將會像在過山車上趕貓一樣困難。毫無疑問,我們從資產負債表上可以了解負債有關的大部分信息。但是,未來的收益更是決定桂林灕江天然生物科技股份有限公司保持健康資產負債表能力的關鍵因素。如果您想了解專業人士的看法,可以查詢分析師盈利預測的免費報告。

Finally, a company can only pay off debt with cold hard cash, not accounting profits. So it's worth checking how much of that EBIT is backed by free cash flow. During the last three years, Guilin Layn Natural Ingredients burned a lot of cash. While investors are no doubt expecting a reversal of that situation in due course, it clearly does mean its use of debt is more risky.

最後,公司只能通過冷硬現金而不是會計利潤來償還債務。因此,檢查其EBIt有多少由自由現金流支持也非常重要。在過去的三年中,桂林灕江天然生物科技股份有限公司燒掉了大量現金。儘管投資者無疑期望這種情況在不久的將來將發生逆轉,但這顯然意味着其債務使用更具風險性。

Our View

我們的觀點

To be frank both Guilin Layn Natural Ingredients's conversion of EBIT to free cash flow and its track record of (not) growing its EBIT make us rather uncomfortable with its debt levels. But at least it's pretty decent at managing its debt, based on its EBITDA,; that's encouraging. Once we consider all the factors above, together, it seems to us that Guilin Layn Natural Ingredients's debt is making it a bit risky. That's not necessarily a bad thing, but we'd generally feel more comfortable with less leverage. When analysing debt levels, the balance sheet is the obvious place to start. However, not all investment risk resides within the balance sheet - far from it. To that end, you should learn about the 4 warning signs we've spotted with Guilin Layn Natural Ingredients (including 1 which is a bit concerning) .

實事求是地說,桂林灕江天然生物科技股份有限公司將EBIt轉化爲自由現金流的能力以及其EBIt的增長軌跡都使我們對其債務水平感到不安。但至少從其EBITDA來看,它在管理債務方面做得還不錯,這是令人鼓舞的。綜合考慮上述所有因素,我們認爲桂林灕江天然生物科技股份有限公司的債務水平有點冒險。這並不一定是壞事,但如果槓桿比率更低,我們會更加放心。在分析債務水平時,資產負債表是開始的明顯位置,但並不意味着所有的投資風險都來自資產負債表。爲此,您應了解我們發現的關於該公司的4個警告信號(包括一個有點令人擔憂的信號)。

Of course, if you're the type of investor who prefers buying stocks without the burden of debt, then don't hesitate to discover our exclusive list of net cash growth stocks, today.

當然,如果您是那種喜歡購買沒有負債負擔的股票的投資者,則今天就可以發現我們的獨家淨現金增長股清單。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有反饋?關於內容有所顧慮?直接和我們聯繫。或者,發送電子郵件至editorial-team (at) simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論